Free delivery for purchases over 59.99 €
Slovak post 4.49 SPS courier 4.99 GLS courier 3.99 GLS point 2.99 Packeta courier 4.99 Packeta point 2.99 SPS Parcel Shop 2.99

Language EnglishEnglish
Book Paperback
Book Ketamine Soichiro Ide
Libristo code: 35372707
Publishers Springer Verlag, Singapore, March 2021
This book presents the latest data from basic research and clinical trials supporting the effectiven... Full description
SALE SALE
168.76
Low in stock Shipping within 24 hours

30-day return policy


You might also be interested in


TOP
Curse For True Love Stephanie Garber / Paperback
common.buy 15.03
TOP
Microdosing with Amanita Muscaria Baba Masha / Paperback
common.buy 16.76
TOP
Botanicum Coloring Book Maria Trolle / Hardback
common.buy 15.64
TOP
Perfect Blue Yoshikazu Takeuchi / Paperback
common.buy 12.98
SALE
Evermore (Deluxe Edt.) / Audio CD
common.buy 16.25
Mystical Healing Reading Cards Jack Baddeley / Paperback
common.buy 20.86
Ketamine for Depression Dr. Stephen J. Hyde / Paperback
common.buy 17.99
Britannica First Big Book of Why Sally Symes / Hardback
common.buy 23.41
Saga Box Set: Volumes 1-9 Brian K Vaughan / Paperback
common.buy 104.42
SALE
Ecstasy: 3,4-Methylenedioxymethamphetamine Alan Philmann / Paperback
common.buy 8.48
Speed, Ecstasy, Ritalin Leslie L. Iversen / Paperback
common.buy 77.73
Ketamine / Paperback
common.buy 15.23
Ketamine Kenji Hashimoto / Hardback
common.buy 199.85

This book presents the latest data from basic research and clinical trials supporting the effectiveness of ketamine as a treatment for depression, bipolar disorder, and suicidal behavior, setting these positive findings within the context of the serious problem of ketamine abuse. The first part of the book focuses on the evidence regarding ketamine abuse, with specific reference to Asian countries, and discusses countermeasures and complication management. It then addresses the mechanisms underlying the antidepressant and side effects of ketamine, which have remained elusive, describing and discussing important new research findings. Further, it explains insights gained from whole brain imaging in rodents and from behavioral pharmacology, and presents evidence regarding the role of gut microbiota, the NMDA receptor GluN2D subunit, and the lateral habenula in the actions of ketamine. These advances form the basis for the safer use of ketamine in patients with treatment-resistant depression and are expected to lead to the development of new antidepressants.

Give this book today
It's easy
1 Add to cart and choose Deliver as present at the checkout 2 We'll send you a voucher 3 The book will arrive at the recipient's address

Login

Log in to your account. Don't have a Libristo account? Create one now!

 
mandatory
mandatory

Don’t have an account? Discover the benefits of having a Libristo account!

With a Libristo account, you'll have everything under control.

Create a Libristo account